Stephen L. Sabba
Director · LIGAND PHARMACEUTICALS INC
- 2026
- Jun 18, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen L. Sabba files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Octavio Espinoza - $13.03M in LGND purchases and sales in the last 12 months
- Andrew Reardon - $10.29M in LGND purchases and sales in the last 12 months
- Jason Haas - $3.74M in LGND purchases and sales in the last 12 months
- John L. Lamattina - $2.44M in LGND purchases and sales in the last 12 months
- Nancy Ryan Gray - $1.35M in LGND purchases and sales in the last 12 months
- Jason Aryeh - $1.25M in LGND purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephen L. Sabba?
Stephen L. Sabba is a corporate insider, tracked as Director of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Stephen L. Sabba last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 4 filings going back to 2026.
Has Stephen L. Sabba been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($1.16M) across all tracked filings.
